Brazil prepares viral hepatitis strategy
This article was originally published in Clinica
Executive Summary
Brazil is close to completing a survey of cases of viral hepatitis A, B and C in each of its state capitals, in a bid to determine prevalence rates and risk factors, with a view to updating its prevention strategies. In the case of hepatitis A, the survey will cover the 5-19-year age range; the HBV and HCV surveys will target the 10-69 age range. The survey will comprise data from a total of 31,000 people. This week saw the launch of a survey of 1,700 people in Rio de Janeiro, which together with Sao Paulo (launched recently) and Espirito Santo and Minas Gerais (due to commence soon) comprise the state capitals of the South East region and some of the country's largest conurbations. The surveys for the remaining four, including the federal district (Brasilia), are all but complete.
You may also be interested in...
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.